Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Polycystic ovary syndrome (PCOS), and one of its distinguishing characteristics, oligomenorrhea, have both been associated with ovarian cancer risk in some but not all studies. However, these associations have been rarely examined by ovarian cancer histotypes, which may explain the lack of clear associations reported in previous studies. Methods: We analyzed data from 14 case–control studies including 16,594 women with invasive ovarian cancer (n = 13,719) or borderline ovarian disease (n = 2,875) and 17,718 controls. Adjusted study-specific ORs were calculated using logistic regression and combined using random-effects meta-analysis. Pooled histotype-specific ORs were calculated using polytomous logistic regression. Results: Women reporting menstrual cycle length >35 days had decreased risk of invasive ovarian cancer compared with women reporting cycle length ≤35 days [OR = 0.70; 95% confidence interval (CI) = 0.58–0.84]. Decreased risk of invasive ovarian cancer was also observed among women who reported irregular menstrual cycles compared with women with regular cycles (OR = 0.83; 95% CI = 0.76–0.89). No significant association was observed between self-reported PCOS and invasive ovarian cancer risk (OR = 0.87; 95% CI = 0.65–1.15). There was a decreased risk of all individual invasive histotypes for women with menstrual cycle length >35 days, but no association with serous borderline tumors (Pheterogeneity = 0.006). Similarly, we observed decreased risks of most invasive histotypes among women with irregular cycles, but an increased risk of borderline serous and mucinous tumors (Pheterogeneity < 0.0001). Conclusions: Our results suggest that menstrual cycle characteristics influence ovarian cancer risk differentially based on histotype. Impact: These results highlight the importance of examining ovarian cancer risk factors associations by histologic subtype. Cancer Epidemiol Biomarkers Prev; 27(2); 174–82. ©2017 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721 · cited 1×
“However, other studies have observed increased risks of ovarian cancer among women with oligomenorrhea (7, 14).”
BackgroundSelf-citationYildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I., & Yarali, H. (2012) · Human Reproduction · doi:10.1093/humrep/des232 · Cited by 704
Menstrual cycle irregularity and risk for future cardiovascular disease
Solomon, C. G., Hu, F. B., Dunaif, A., Rich-Edwards, J. E., Stampfer, M. J., Willett, W. C., Speizer, F. E., & Manson, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8471 · Cited by 528
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504
THE EPIDEMIOLOGY OF POLYCYSTIC OVARY SYNDROME
Solomon, C. G. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70069-4 · Cited by 226 · cited 1×
“While PCOS has been examined as a risk factor for ovarian cancer in multiple studies (1–9), results have been inconsistent, due in part to the inherent limitations in assessing PCOS in a population-based study (10).”
BackgroundAre young adult women with polycystic ovary syndrome slipping through the healthcare cracks?
Dokras, A., & Witchel, S. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4190 · Cited by 43
Cited by
Global epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00881-3 · Cited by 571
Self-citationGestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes
Alejandro, E. U., Mamerto, T. P., Chung, G., Villavieja, A., Gaus, N. L., Morgan, E., & Pineda-Cortel, M. R. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145003 · Cited by 353
Li, Z., Wang, Y.-H., Wang, L.-L., Hu, D.-T., Teng, Y., Zhang, T.-Y., Yan, Z.-Y., Wang, F., & Zou, Y.-F. (2022) · Scottish Medical Journal · doi:10.1177/00369330221107099 · Cited by 40
“It should be noted that one article included nine case-control studies investigating the association between invasive ovarian cancer and self-reported PCOS.32 Since two of them were repeated with other studies we have already included,24, 30 we extracted seven of them from this article.”
BackgroundInfluentialMedicinal Traits of the Phenolic Compound from Foeniculum vulgare for Oligomenorrhea
Patil, J., Patil, D., Sayyed, H., Patil, M., & Mali, R. (2022) · The 26th International Electronic Conference on Synthetic Organic Chemistry · doi:10.3390/ecsoc-26-13724 · Cited by 6
“Patients with PCOS, in particular, have expressed symptoms of irregular ovulation, and 75% to 85% of them are thought to suffer oligomenorrhea [11].”
Background
Metadata
- Authors
- Harris, H. R., Babic, A., Webb, P. M., Nagle, C. M., Jordan, S. J., Risch, H. A., Rossing, M. A., Doherty, J. A., Goodman, M. T., Modugno, F., Ness, R. B., Moysich, K. B., Kjær, S. K., Høgdall, E., Jensen, A., Schildkraut, J. M., Berchuck, A., Cramer, D. W., Bandera, E. V., Wentzensen, N., Kotsopoulos, J., Narod, S. A., Phelan, C. M., McLaughlin, J. R., Anton-Culver, H., Ziogas, A., Pearce, C. L., Wu, A. H., & Terry, K. L.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2018-02-01
- Volume
- 27
- Issue
- 2
- Pages
- 174-182
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2768376481
- Cited by
- 43
- References
- 9
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. https://app.cochat.ai/papers/10.1158/1055-9965.epi-17-0655
- The paper
- Harris, H. R., Babic, A., Webb, P. M., Nagle, C. M., Jordan, S. J., Risch, H. A., Rossing, M. A., Doherty, J. A., Goodman, M. T., Modugno, F., Ness, R. B., Moysich, K. B., Kjær, S. K., Høgdall, E., Jensen, A., Schildkraut, J. M., Berchuck, A., Cramer, D. W., Bandera, E. V., . . . Terry, K. L. (2018). Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-17-0655
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.